Key result
Transplacental maternal administration of oral digoxin successfully reduced fetal heart rate from 204-220 bpm to 139-156 bpm within 7 days, maintaining sinus rhythm until delivery.
Why the study?
Fetal supraventricular tachycardia is the most common primary fetal tachycardia and can cause non-immune hydrops, significant perinatal morbidity, and mortality.
Comparison
Transplacental maternal oral digoxin therapy
Design
Case report
Authors
Loading...
Maternal oral digoxin may offer a viable transplacental treatment for fetal SVT; leaves open the.
Case Report (n=1)
No
Transplacental maternal oral digoxin successfully treated fetal supraventricular tachycardia, restoring normal sinus rhythm without adverse neonatal outcomes.
Ezeama et al. (2023) conducted a case report in Fetal supraventricular tachycardia (n=1). Transplacental digoxin was evaluated on Fetal heart rate and reversion to sinus rhythm. Transplacental maternal administration of oral digoxin successfully reduced fetal heart rate from 204-220 bpm to 139-156 bpm within 7 days, maintaining sinus rhythm until delivery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: